Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2016-06-02 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: USSON-DU-POITOU (86350), Vienne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE TAKACS : revenue, balance sheet and financial ratios
PHARMACIE TAKACS is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in USSON-DU-POITOU (86350),
this company of category PME
shows in 2020 a net income positive of 87 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE TAKACS (SIREN 820727014)
Indicator
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
Net income
86 846 €
76 893 €
83 501 €
128 606 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2020, PHARMACIE TAKACS generates positive net income of 87 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 129 k€ -> 87 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
86 846 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 169%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
169.44%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.308%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
Debt ratio
580.853
353.545
247.061
169.44
Financial autonomy
12.882
19.448
25.046
33.308
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
169.442020
2018
2019
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average-12 pts over 3 years
In 2020, the debt ratio of PHARMACIE TAKACS (169.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
33.31%2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Average+14 pts over 3 years
In 2020, the financial autonomy of PHARMACIE TAKACS (33.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 213.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
213.48
Liquidity indicators evolution PHARMACIE TAKACS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
Liquidity ratio
169.191
179.178
180.185
213.48
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
213.482020
2018
2019
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Good
In 2020, the liquidity ratio of PHARMACIE TAKACS (213.48) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE TAKACS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of PHARMACIE TAKACS is estimated at
1 227 364 €
(range 818 389€ - 1 656 046€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
818k€1227k€1656k€
1 227 364 €Range: 818 389€ - 1 656 046€
NAF 5 année 2020
Valuation method used
Net Income Multiple
86 846 €
×
14.1x
=1 227 365 €
Range: 818 390€ - 1 656 046€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE TAKACS with other companies in the same sector:
The revenue of PHARMACIE TAKACS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE TAKACS profitable?
Yes, PHARMACIE TAKACS generated a net profit of 87 k€ in 2020.
Where is the headquarters of PHARMACIE TAKACS ?
The headquarters of PHARMACIE TAKACS is located in USSON-DU-POITOU (86350), in the department Vienne.
Where to find the tax return of PHARMACIE TAKACS ?
The tax return of PHARMACIE TAKACS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE TAKACS operate?
PHARMACIE TAKACS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart